Supreme Court Abortion Pill Mail-Ban Raises Health and Privacy Worries – The Spectator
Supreme Court Abortion Pill Mail-Ban Raises Health and Privacy Worries – The Spectator
Publish Date: 2026-05-14 00:57:00
Source Domain: seattlespectator.com
Last week, the Supreme Court ruled to block the mail order of mifepristone, a thoroughly tested progesterone-blocking medication with many uses. Along with terminating pregnancies within their first 70 days, mifepristone treats miscarriages, uterine fibroids and other medical conditions. The decision to block this medication was met with swift backlash from pharmaceutical companies that claimed the decision had caused sudden chaos and confusion in the world of reproductive healthcare, and a short-term administrative stay went into effect May 4. This administrative stay paused the block, allowing mifepristone mail delivery to continue until Thursday, May 14.
Since the Dobbs decision overturned Roe v. Wade in 2022, ruling that the right to abortion is not encoded in the Constitution, the mifepristone block has been one of many obstacles for those seeking reproductive healthcare.
Erin Carr, a law professor at Seattle University who specializes in areas of educational inequality, juvenile and criminal justice, power and privilege and constitutional law, explained the 2022 ruling.
“The reasoning of Dobbs is that there are no constitutional protections to be found in the 14th Amendment that would provide privacy-based rights to make these decisions about bodily autonomy,” Carr said.
Dobbs left the issue of reproductive rights to individual states, 28 of which now have abortion bans based on gestational period, and 13 of which have banned abortions entirely. Although many states still ensure access to abortion, such as Washington, which says it will stockpile mifepristone, this new ban will be felt on a national scale, unlike preceding restrictions which vary state to state.
The ban will affect medical practitioners like Dr. Wendy Smith, a Portland-based obstetrician-gynecologist.
“It’s taking a safe and effective drug and making us use alternatives that are not as safe and not as effective,” Smith said.
She outlined the…
